Oct 28, 2026 earnings call — Record shipments and updated Q4, 2026 outlook
Align reported worldwide Q3 revenue of $1.015 billion while Clear Aligner shipments reached 691,000.
Revenue $1.0B (est $1.0B) · EPS $2.80 (est $2.77) · Next-quarter revenue outlook $1.0B–$1.0B
Key quotes
"We continue to drive adoption utilization across customer channels. That includes increasing utilization among orthodontists, expanding Invisalign adoption among GP dentists and growing with DSOs and strategic accounts."
"Revenue continues to reflect a shift towards lower-priced scanner configurations and more flexible acquisition models and stable ASP on a like-for-like basis, while our installed base and customer footprint continue to expand."
"Our Zero Additional Aligner offering providing doctors with a greater treatment and pricing flexibility while patient financing and commercial programs are designed to help practices convert more prospective patients."
Analyst Q&A 10
case starts and consumer demand
Q (Michael Cherny · Leerink Partners): Analyst asked why Q3 case starts were strong but Q4 guidance was weaker and what leading indicators or drivers changed between quarters.
A: Management said Q3 was strong but they now see a broadly challenged consumer across many countries, which they used to set their Q4 guidance.
"As we look at the fourth quarter, we see continued challenged consumer overall." — Joseph Hogan (CEO)
new mouthguard product strategy
Q (Jonathan Block · Stifel): Analyst asked whether the sports mouthguard signals a move into adjacent products or 3D printing, and how Align views these opportunities.
A: Management said they developed a unique resin and 3D-print capability that gives design flexibility and matches their existing dentist/orthodontist channels, so they can sell through current channels without friction.
"The reason I wanted -- I thought it was time to do this is we have a unique resin we've developed." — Joseph Hogan (CEO)
exposure to China public vs private market
Q (Brandon Vazquez · William Blair): Analyst asked how much of Align's China business is public versus private and how VBP (volume-based procurement) might affect them.
A: Management said they have limited exposure on the public side and most business in China is private, and they plan to participate as VBP opens further.
"Only about 15% of our business in China is public." — John Morici (CFO)
2027 margin improvement drivers
Q (Vikramjeet Chopra · BMO): Analyst asked what drives the targeted 100 basis points of margin improvement in 2027 without a consumer recovery and whether strategic review could add to that.
A: Management said productivity and efficiency programs, plus product simplification and manufacturing scale, are driving gross margin and productivity gains that support the op margin improvement plan.
"We have a lot of productivity and efficiency programs in place." — John Morici (CFO)
net impact of China VBP
Q (Jeffrey Johnson · Baird): Analyst asked whether VBP in China would be net positive or negative given potential price pressure in private market versus incremental public volumes.
A: Management said VBP has many moving parts but they expect increased volume that should offset some price pressure, and overall they view the net effect as neutral to positive given their in-China operations.
"To us, it's neutral to positive, just from the standpoint, you're going to drive a lot of volume, I think, as it works its way through the system." — John Morici (CFO)
scanner sales, leasing, and demand
Q (Elizabeth Anderson · Evercore): Analyst asked why scanner revenue guidance seemed lower and wanted detail on unit mix, leasing, and how upgrade cycles and pricing trends affect demand.
A: Management said unit volume for scanners is very strong with a growing installed base; doctors choose full systems, flex models, certified preowned, or leasing, and leasing shifts revenue timing but helps adoption.
"The scanner equipment sales that we have, the unit volume has been very strong." — John Morici (CFO)
assumptions behind 2027 outlook
Q (Jason Bednar · Piper Sandler): Analyst asked what macro assumptions underpin the 2027 clear aligner outlook and what drives ASP changes in the framework.
A: Management said they are not expecting much consumer improvement and plan to use product, go-to-market, and financing levers; ASPs are pressured by geography and product mix, roughly a 1% to 2% headwind.
"When we look at 2027 framework, first off, we're not expecting much of a change in the overall consumer." — John Morici (CFO)
sustainability of scanner pricing shift
Q (Steven Valiquette · Mizuho): Analyst asked whether the shift to leasing and lower-priced scanner purchases is secular and if pricing has bottomed.
A: Management said they expect the pricing shift has stabilized, demand and installed base are strong, and leasing trades upfront revenue for longer-term returns while driving digitization.
"When you think of what we're trying to do is, we're expecting a challenging macro environment." — John Morici (CFO)
financing rollout and competition from brackets/wires
Q (Erin Wilson Wright · Morgan Stanley): Analyst asked about rollout and impact of new consumer financing programs on conversion, and whether share is shifting back to traditional braces.
A: Management said financing is expanding across many countries and helping win gray-area patients; they also said many products (Invisalign First, IPE, Mandibular Advancement) are growing at double digits and support youth access.
"We're seeing many countries and many regions adopting financing, using external financing that really haven't done it before." — John Morici (CFO)
mouthguard distribution and pricing
Q (Kevin Caliendo · UBS): Analyst asked whether the mouthguard will be sold in retail or only through dental channels, and whether it is premium and could affect retainer sales.
A: Management said they will not sell directly to consumers and will distribute through orthodontists and GPs; it is a premium, distinct 3D-printed product and should not hurt the retainer business.
"First of all, we won't be selling it directly to consumers." — Joseph Hogan (CEO)